MarketInOut Stock Screener Log In | Sign Up
 

Natera Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/05/2026 16:00
Natera Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization58,582 mln
Float135 mln
Earnings Date11/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

0.29
Highly suspicious

1-Year Forecast

361.16
Downside risk

Relative Strength

96 / 100
Top performer

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-9%
Marginally loss-making

Business Description

Founded in 2003 and based in Austin, Texas, Natera develops and sells genetic testing services for use across oncology, women's health, and organ transplant care. Its tests help detect cancer recurrence, screen for hereditary conditions, support prenatal care, and monitor kidney and transplant health. The company works with hospitals, physician practices, research labs, and pharmaceutical companies, and also offers cloud-based software that allows partner labs to distribute its testing under license.

Key Fundamentals

EPS-1.35
ROE-12.32
RPS19.32
ROIC-21.67
ROA-8.47
Interest Cover-29.04
EBITDA, mln-183
EV / EBITDA-328
EV / EBIT-242
Revenue, mln2,707
EV / Revenue22.21

Quote Details

Last 425.64
Change 15.29 (3.73%)
Open 410.32
Volume 2,018,273
Turnover 859,057,728
Average Volume 1,633,354

Financial Ratios

Pre-Tax Profit Margin-9
Leverage Ratio1.46
Current Ratio3.00
Price / Book33.42
Price / Tangible Book46.11
Price / Cash Flow255
Price / Free Cash Flow697
Debt / Equity0.13
Price / Sales21.95

Financial Strength

Altman Z-Score42.55
Piotroski F-Score 5 / 9
Beneish M-Score0.29
1-Year Target Price361.16
Short Ratio4.12
Short % of Float3.43

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.37% 84 / 100   
1 Month 29.9% 96 / 100   
2 Months 56.31% 97 / 100   
6 Months 108% 97 / 100   
1 Year 166% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us